• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    SELLAS Life Sciences Group, Inc. - Common Stock (NQ:SLS)

    3.660 +0.070 (+1.95%)
    Streaming Delayed Price Updated: 4:00 PM EST, Feb 17, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 4,090,361
    Open 3.590
    Bid (Size) 3.660 (1,900)
    Ask (Size) 3.680 (2,500)
    Prev. Close 3.590
    Today's Range 3.520 - 3.750
    52wk Range 0.9516 - 5.176
    Shares Outstanding 15,873,941
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    SLS Stock In Spotlight On EU Expansion For Cancer Therapy – Retail Says Potential Catalyst For Buyout ↗
    The IMPACT-AML program will conduct a European clinical study evaluating SLS009 and provide SELLAS access to multiple clinical sites and a broader patient population. 
    Via Stocktwits
    SELLAS Life Sciences Falls For Fourth Straight Session — What’s Driving The Sell Off? ↗
    Via Stocktwits

    Performance

    YTD
    -15.9%
    -15.9%
    1 Month
    -15.3%
    -15.3%
    3 Month
    +159.6%
    +159.6%
    6 Month
    +111.6%
    +111.6%
    1 Year
    +188.2%
    +188.2%

    More News

    Read More
    News headline image
    The $170B Survival Race: Why Big Pharma is Snapping Up Late-Stage Cancer Tech
    From Equity Insider
    Via GlobeNewswire
    Top movers analysis one hour before the close of the markets on 2026-01-06: top gainers and losers in today's session. ↗
    Via Chartmill
    Why Is SELLAS Life Sciences Stock Falling Today? ↗
    Via Stocktwits
    Let's have a look at the top gainers and losers in the middle of the day of today's session. ↗
    Via Chartmill
    News headline image
    Nasdaq, S&P 500 Futures Edge Lower Despite CES-Driven AI Optimism: Why NVDA, TSLA, AMD, AEVA, OS Are On Traders' Radar Today ↗
    Via Stocktwits
    Topics Artificial Intelligence ETFs Stocks
    News headline image
    SLS Stock Breaches $5 Level After Over 3 Years: Retail Now Eyes Buyout For As Much As $25B ↗
    Via Stocktwits
    Topics Death
    News headline image
    Why Is SLS Stock Drawing Significant Investor Attention Today? ↗
    Via Stocktwits
    Topics Death
    News headline image
    Biopharma’s Year-End Rollercoaster: Mereo Plummets 90% as BioMarin Seals $4.8 Billion Amicus Deal
    Via MarketMinute
    Topics ETFs Intellectual Property
    News headline image
    SELLAS Life Sciences Group Stock Soars As It Nears Final Analysis In Cancer Study ↗
    Via Stocktwits
    Topics Death
    News headline image
    SLS Stock Has Risen 78% In A Month — What’s The Retail Buzz About? ↗
    Via Stocktwits
    News headline image
    Precision's Payoff: Targeted Therapies Drive $131B Solid Tumor Market Surge
    From Equity Insider
    Via GlobeNewswire
    News headline image
    These stocks are gapping in today's session ↗
    Via Chartmill
    News headline image
    SELLAS Life Sciences Stock Has Doubled This Year – Here’s Why Retail Investors Are Bullish ↗
    Via Stocktwits
    Topics Death
    News headline image
    SELLAS Life Sciences Draws Retail Buzz On SLS009 Trial Momentum – Stock Soars In Pre-Market ↗
    Via Stocktwits
    Topics Artificial Intelligence
    News headline image
    10 Health Care Stocks With Whale Alerts In Today's Session ↗
    Via Benzinga
    News headline image
    Papa John's Is Not First: Here Are 3 Other Stocks Rocked By Market-Moving Fake News ↗
    Via Benzinga
    News headline image
    These stocks are moving in today's after hours session ↗
    Via Chartmill
    News headline image
    Sellas Life Sciences Stock Jumps Over 7% Premarket: Buzz Builds Ahead Of Weekend Cancer Drug Presentation In Berlin ↗
    Via Stocktwits
    News headline image
    SELLAS Life Sciences Stock Rises On Strong Preclinical Data For Investigational Cancer Treatment ↗
    Via Stocktwits
    News headline image
    Sellas Life Sciences Stock In Spotlight After Institutional Investor Exercises Existing Warrants ↗
    Via Stocktwits
    News headline image
    SELLAS Life Sciences Group Inc (NASDAQ:SLS) Reports Q2 2025 Earnings: Narrower Loss and Clinical Progress Amid Revenue Challenges ↗
    Via Chartmill
    News headline image
    Wall Street Eyes Breakout Cancer Therapies Amid Soaring Drug Prices
    Via FinancialNewsMedia
    News headline image
    Thursday's after hours session: top gainers and losers ↗
    Via Chartmill

    Frequently Asked Questions

    Is SELLAS Life Sciences Group, Inc. - Common Stock publicly traded?
    Yes, SELLAS Life Sciences Group, Inc. - Common Stock is publicly traded.
    What exchange does SELLAS Life Sciences Group, Inc. - Common Stock trade on?
    SELLAS Life Sciences Group, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for SELLAS Life Sciences Group, Inc. - Common Stock?
    The ticker symbol for SELLAS Life Sciences Group, Inc. - Common Stock is SLS on the Nasdaq Stock Market
    What is the current price of SELLAS Life Sciences Group, Inc. - Common Stock?
    The current price of SELLAS Life Sciences Group, Inc. - Common Stock is 3.660
    When was SELLAS Life Sciences Group, Inc. - Common Stock last traded?
    The last trade of SELLAS Life Sciences Group, Inc. - Common Stock was at 02/17/26 04:00 PM ET
    What is the market capitalization of SELLAS Life Sciences Group, Inc. - Common Stock?
    The market capitalization of SELLAS Life Sciences Group, Inc. - Common Stock is 58.10M
    How many shares of SELLAS Life Sciences Group, Inc. - Common Stock are outstanding?
    SELLAS Life Sciences Group, Inc. - Common Stock has 58M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.